Lakeside Holding
| Company type | Public |
|---|---|
| Nasdaq: LSH | |
| Industry | Logistics |
| Founded | 2018 |
| Headquarters | Itasca, Illinois, U.S |
Key people | Henry Liu (CEO) Shuai Li (COO) |
| Revenue |  US$4.08 million (2024) |
| US$0.24 million (2024) | |
Number of employees | 50+ (2024) |
| Website | lakeside-holding |
Lakeside Holding Limited (Nasdaq: LSH) is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market, including China and South Korea. Operating under the brand American Bear Logistics, the company offers customized cross-border ocean and air freight solutions tailored to clients' needs for transporting goods into the United States.
History
[edit]Lakeside Holding Limited was founded in 2018 and is headquartered in Itasca, Illinois. The company has established itself in the logistics industry by providing services to logistics companies serving e-commerce platforms, social commerce platforms, and manufacturers. It is Asian American-owned and leverages an in-depth understanding of both U.S. and Asian international trading and logistics service markets.
Services
[edit]The company specializes in:
- Cross-border freight consolidation and forwarding
- Customs clearance
- Warehousing and distribution
- Domestic ground transportation
These services cater to the transportation of consumer and industrial goods from Asia to the U.S., addressing specific client requirements.
Initial Public Offering (IPO)
[edit]On June 28, 2024, Lakeside Holding Limited commenced trading on the Nasdaq Capital Market under the ticker symbol "LSH". The company offered 1.5 million shares at a public offering price of $4.50 per share, resulting in total gross proceeds of $6.75 million before underwriting discounts and offering expenses.[1]
Recent Developments
[edit]In November 2024, Lakeside Holding Limited expanded into the medical logistics sector by acquiring Hupan Pharmaceutical (Hubei) Co., Ltd., a comprehensive pharmaceutical distribution and supply chain service provider based in Wuhan, China.[2] The acquisition is projected to add approximately $7 million in annual revenue.
Following the acquisition of Hupan Pharmaceutical, the company entered a partnership with Sinopharm Hubei, a subsidiary of Sinopharm Group Co., Ltd.[3] This collaboration aims to support comprehensive pharmaceutical distribution needs, highlighting the growing demand for specialized logistics and supply chain solutions in China's healthcare market.
Financial Performance
[edit]For the first quarter of fiscal year 2025, ending September 30, 2024, Lakeside reported total revenues of $4,081,554.[4] This represented a slight decrease compared to the same period in the previous year, primarily due to a reduction in revenues from cross-border airfreight solutions, partially offset by an increase in cross-border ocean freight solutions.[5][6][7][8][9]
References
[edit]- ^ "Lakeside Holding Limited Announces Closing of Upsized $6.75 Million Initial Public Offering". nasdaq.com. 2024-07-01. Retrieved 2024-11-28.
- ^ "Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd". prnewswire.com. Retrieved 2024-11-28.
- ^ "Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm (Hubei) Contracts". www.taiwannews.com.tw. Retrieved 2024-11-28.
- ^ "LAKESIDE HOLDING PROVIDES FIRST QUARTER OF FISCAL YEAR 2025 RESULTS". prnewswire.com. Retrieved 2024-11-28.
- ^ "Lakeside Holding Limited (LSH) Company Information". Stock Analysis. Retrieved 2024-11-28.
- ^ "Lakeside Holding Limited (LSH) on Yahoo Finance". finance.yahoo.com.
- ^ "Check out Lakeside Holdings Ltd's stock price (LSH) in real time". CNBC. Retrieved 2024-12-02.
- ^ "Lakeside Holding Ltd. | IPOScoop". Retrieved 2024-12-03.
- ^ "Lakeside Holding Ltd - Company Profile and News". Bloomberg.com. Retrieved 2024-12-03.